The Canadian Press on MSN
Former CP health reporter Helen Branswell remembered as excellent journalist and loving person
TORONTO — Helen Branswell, the former Canadian Press health reporter known for her award-winning infectious disease coverage, ...
FLINTLOCK Phase 2 clinical trial will evaluate the safety, tolerability, pharmacokinetics, and clinical efficacy of high-dose monoclonal antibody ...
And what the researchers saw after the vapor stopped was the more worrying part.
Spread the loveImagine a world where detecting deadly viruses like HIV, influenza, or even the next emergent pathogen isn’t a ...
Pfizer Inc. (NYSE: PFE) will present data from more than 50 company-sponsored, investigator-sponsored and collaborative research abstracts across its infectious disease pipeline and portfolio at the ...
A new study has linked inflammation-causing bacteria in the microbiome to fever following Covid-19 vaccines. Importantly, ...
Invivyd, Inc. and the SPEAR Study Group announced the initiation of FLINTLOCK, a Phase 2 clinical trial evaluating the safety, tolerability, pharmacokinetics, and clinical efficacy of high-dose ...
Scientists have long used a powerful gene-editing tool called CRISPR to make precise changes to DNA. But a different version ...
Rice University researchers modified Cas13a, increasing its sensitivity for detecting a synthetic noninfectious HIV sample ...
This summer’s COVID-19 wave is pushing into the fall. Data through early October show disease levels are still highest in the ...
A new review in the Journal of Molecular Medicine explains how trained immunity, driven by epigenetic and metabolic ...
More than 133,000 children visited the emergency departments of Greece’s two major pediatric hospitals in 2025, as new data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results